Passage Bio, Inc.
USD4.82
-0.04 (-0.72%)
CEO
William Chou
IPO Date
2020-02-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.90
Prev. Close
$4.85
Day Low
$4.76
Day High
$4.93
52W Low
$3.29
52W High
$20.00
Market Cap
$0.02B
Volume
0.02M
| -0.5 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -91.7% | -67.8% | 0.24 | 7.22 | -0.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -67.6% | -55.9% | 0.13 | 10.74 | -0.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -58.2% | -52.2% | 0.00 | 11.02 | -1.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -36.8% | -34.2% | 0.00 | 14.98 | -10.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -26.2% | -25.5% | 0.00 | 45.04 | -11.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 104.9% | -38.2% | 0.00 | 108.79 | -41.7 |
| -0.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -24.9% | -10.4% | 0.78 | 2.51 | -0.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -24.5% | -11.9% | 0.65 | 3.05 | -0.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -33.0% | -17.9% | 0.54 | 3.74 | -0.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -20.8% | -12.4% | 0.42 | 4.07 | -0.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -26.6% | -17.3% | 0.36 | 5.15 | -0.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -17.7% | -12.8% | 0.29 | 7.67 | -0.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -15.9% | -11.9% | 0.25 | 8.43 | -1.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -15.1% | -11.1% | 0.24 | 7.22 | -0.8 |